Melinta Therapeutics, Inc. (NASDAQ:MLNT)

7.25
Delayed Data
As of 10:18am ET
 +0.15 / +2.11%
Today’s Change
6.50
Today|||52-Week Range
24.25
-54.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-61.6M-91.1M-118.0M-58.9M
 
 
 
 
 
Depreciation76.3K69.2K51.0K451.0K
 
 
 
 
 
Total Other Cash Flow3.8M6.4M14.4M-15.8M
 
 
 
 
 
Funds From Operations-57.8M-84.6M-103.5M-74.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-8.7M3.2M-16.4M1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-49.1M-87.8M-87.1M-75.6M
 
 
 
 
 
 
InvestingCapital Expenditures-51.7K-45.8K-9.0K-849.0K
 
 
 
 
 
Fixed Asset Disposal------161.4M
 
 
Net Cash Flow Investing-51.7K-45.8K-9.0K155.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00----0.00--
Long Term Borrowings3.0M19.7M0.0024.5M
 
 
 
 
Long Term Debt Reduction0.00-19.0M-4.4M-24.5M
 
 
 
 
Net Proceeds Stock Sale48.8M141.9M169.3M38.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.001.2M
 
 
Net Cash Flow - Financing51.8M142.5M164.9M37.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash2.6M54.7M77.8M117.2M